Nuritas Ltd. news
Ingredients for muscle mass and post-workout recovery remain mainstays in sports nutrition, but the category is evolving and broadening. Ingredient examples are phospholipids for cognition and probiotic cultures for digestive health.
“It’s very well-known that health is increasingly perceived holistically by consumers, especially younger demographics,” said Paige Wilkinson, global marketing manager, active living for Fonterra and based in Auckland, New Zealand. &ldqu
Nuritas were thrilled to be part of the Foresight Vision Weekend and join this international community in discussing transformative innovation in biotechnology and beyond.
The Foresight Institute focuses on advancing high-impact technology key to the long term future of life. Our founder & CEO Dr Nora Khaldi shared how Nuritas is using AI to unlock the power of nature and deliver health focused solutions.
Nuritas, a biotechnology company revolutionizing the discovery and development of plant-based bioactive peptides, has closed a $45 million USD Series B funding round. The investment, led by Chicago-based Cleveland Avenue, LLC, includes Grosvenor’s Wheatsheaf Group
Nuritas were thrilled to be part of this milestone event highlighting the latest innovations in artificial intelligence across Europe, a High-Level Conference on AI: from Ambition to Action.
Presented by the European Commission, the conference engaged thousands in a dialogue on the future of AI in Europe. Our founder & CEO Dr Nora Khaldi discussed Nuritas thought leadership in this space in her keynote speech “The potential of human-centric AI innovation for healthcare and w
We are delighted to announce the appointment of Gaby Vreeken as the new Chief Growth Officer of Nuritas.
Gaby brings over 30 years of experience in Fast Moving Consumer Goods across local, regional and global markets. He is an expert in business strategy, brand building and innovation, both in the consumer and B2B space. His most recent role was Global Chief Marketing Officer and Executive Board member for the Consumer Health division of Bayer, where he led sales & marketing funct
Sumitomo Chemical Co., Ltd. and Nuritas announced today that they have signed a multi-year partnership to sustainably support the food production systems needed to feed the growing global population.
This hugely important partnership will see Nuritas deploy its award-winning and novel technology platform, which uses Artificial Intelligence and DNA analysis to predict, unlock, and validate highly efficacious peptides, from plant sources. Sumitomo Chemical Co., Ltd.&
Nuritas, the world leader in artificial intelligence-based natural molecule discovery, has published an independent peer reviewed scientific paper in Foods Journal. The paper outlines the discovery of natural rice-based peptides clinically proven to impact inflammation and improve physical test results in an elderly population.
Whilst these peptides are found within food, critically, their health benefit cannot be achieved by simply eating rice. Nuritas’ unique approach is